Corporate Presentation
Consistent History of Execution
PROGRESSING THE PIPELINE
2017
Cavro P1
in healthy
subjects
●
brooks
2018
Cavro P1
complete
XCUR17 P1
complete
NEW 30,000 FT² FACILITY
Brooks
● Neuro
●
2019
●
GROWING THE FACILITIES
expansion
Cavro P1b/2
Allergan
partnership
~30
MEMBERS
(2019)
2020
● Cavro P2
●
XCUR-FXN
selected
TEAM EXPANSION
~60
MEMBERS
(2020)
David Giljohann, PhD
CEO
Timothy Walbert
illumina
V
valneva
Chairman
NORTHWESTERN
UNIVERSITY
AUGMENTING THE TEAM
Jeffrey Cleland,
PhD
HARVARD
UNIVERSITY
MANAGEMENT
Chad Mirkin, PhD
Co-founder
Matthias Schroff, PhD
COO
BOARD
MOLOGEN AG
Orpheris
VAXIMM
David Walt,
PhD
HORIZON
PHARMA
Bali Muralidhar,
BM BCh, PhD
Momenta™
AuraSense
VERSARTIS
Doug Feltner, MD
CMO
abbvie
James Sulat
Bosun Hau
Quanterix
Pfizer avegis
NORTHWESTERN UNIVERSITY
MFEINBERG
SCHOOL OF MEDICINE
exicure |
6View entire presentation